Abstract:Nerve growth factor (NGF), by binding to TrkA and p75NTR receptors, regulates the survival and differentiation of sensory neurons during development and mediates pain transmission and perception during adulthood, by acting at different levels of the nervous system. Key to understanding the role of NGF as a pain mediator is the finding that mutations (namely, R121W, V232fs and R221W) in the NGF gene cause painlessness disease Hereditary Sensory and Autonomic Neuropathy type V (HSAN V). Here we shall review the consequences of these NGF mutations, each of which results in specific clinical signs: R221W determines congenital pain insensitivity with no overt cognitive disabilities, whereas V232fs and R121W also result in intellectual disability, thus showing similarities to HSAN IV, which is caused by mutations in TrkA, rather than to HSAN V. Comparing the cellular, biochemical and clinical findings of these mutations could help in better understanding not only the possible mechanisms underlying HSAN V, but also mechanisms of NGF signalling and roles. These mutations alter the balance between NGF and proNGF in favour of an accumulation of the latter, suggesting a possible role of proNGF as a molecule with an analgesic role. Furthermore, the neurotrophic and pronociceptive functions of NGF are split by the R221W mutation, making NGF variants based on this mutation interesting for designing therapeutic applications for many diseases. This review emphasizes the possibility of using the mutations involved in "painlessness" clinical disorders as an innovative approach to identify new proteins and pathways involved in pain transmission and perception.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Outstanding questions</h3>Why do homozygous HSAN V die postnatally? What is the cause of this early postnatal lethality?Is the development of a mouse or a human feeling less pain affecting higher cognitive and perceptual functions?What is the consequence of the HSAN V mutation on the development of joints and bones? Are the multiple fractures observed in HSAN V patients due exclusively to the carelessness consequent to not feeling pain, or also to an intrinsic frailty of their bones?Are heterodimers of NGFWT and NGFR221W in the heterozygote state formed? And if so, what are the properties of these heterodimeric proteins?How is the processing of proNGFR221W to NGFR221W affected by the mutation?

Haploinsufficiency of the brain-derived neurotrophic factor gene is associated with reduced pain sensitivity

Two Novel<i>SCN9A</i>Gene Heterozygous Mutations May Cause Partial Deletion of Pain Perception

GENES CONTRIBUTING TO PAIN SENSITIVITY IN THE NORMAL POPULATION: AN EXOME SEQUENCING STUDY

Targeted Genotyping Identifies Susceptibility Locus in Brain-derived Neurotrophic Factor Gene for Chronic Postsurgical Pain

Pain perception is altered by a nucleotide polymorphism in SCN9A

A SCN10A SNP Biases Human Pain Sensitivity.

Brain‐derived Neurotrophic Factor Modulates N‐methyl‐D‐aspartate Receptor Activation in a Rat Model of Cancer‐induced Bone Pain

Brain-Derived Neurotrophic Factor, Nociception, and Pain

A Missense Point Mutation in Nerve Growth Factor (NGFR100W) Results in Selective Peripheral Sensory Neuropathy

Peripheral BDNF Regulates Somatosensory–Sympathetic Coupling in Brachial Plexus Avulsion-Induced Neuropathic Pain

Genetic pain loss disorders

Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF

Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity

A missense point mutation in nerve growth factor (NGF<SUP>R100W</SUP>) results in selective peripheral sensory neuropathy

Systems genetics analysis reveals the common genetic basis for pain sensitivity and cognitive function

Long-term male-specific chronic pain via telomere- and p53‑mediated spinal cord cellular senescence

Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling

Brain-derived Neurotrophic Factor Stimulation of T-type Ca 2+ Channels in Sensory Neurons Contributes to Increased Peripheral Pain Sensitivity

Spatial, transcriptomic and epigenomic analyses link dorsal horn neurons to chronic pain genetic predisposition

BDNF Participates in Chronic Constriction Injury-Induced Neuropathic Pain via Transcriptionally Activating P2X7 in Primary Sensory Neurons

Optical genome mapping identifies a homozygous deletion in the non-coding region of the SCN9A gene in individuals from the same family with congenital insensitivity to pain